Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine.

Proteomics - 1 Oct 2004

Fernández-Arenas Elena, Molero Gloria, Nombela César, Diez-Orejas Rosalía, Gil Concha

Abstract excerpt

Several low virulent Candida albicans mutant strains: CM1613 (deleted in the Mitogen Activated Protein (MAP) Kinase MKC1), CNC13 (deleted in the MAP-kinase HOG1) and the morphological mutant 92' were used as vaccines employing a murine model of systemic candidiasis. In this vaccination trial, only the CNC13 strain was able to induce protection against a subsequent infection with a lethal dose of the wild-type...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Fungal
Share to Candida albicans
Share to Databases as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Electrophoresis, Gel, Two-Dimensional

Share to Protoplasts

Share to Silver Staining

Share to Th1 Cells

Share to Th2 Cells

Source

Identifiers

PMID: 15378749
DOI: 10.1002/pmic.200400929

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low virulent strains of Candida albicans: unravelling the antigens for a future vaccine.PMID 15378749Read ↗

Contribution of the antibodies response induced by a low virulent Candida albicans strain in protection against systemic candidiasis.Semantic proximity Read ↗

Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.Semantic proximity Read ↗

Epitope-Based Peptide Vaccine Design Against Fructose Bisphosphate Aldolase of Candida Glabrata: An Immunomics ApproachSemantic proximity Read ↗

Next-generation Candida albicans recombinant Als3p and Hyr1p dual antigen vaccine for invasive Candida infectionsSemantic proximity Read ↗

The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Cryptococcus neoformansSemantic proximity Read ↗

In silico Design of a Multivalent Vaccine Against Candida albicansSemantic proximity Read ↗

A Heat-Killed Cryptococcus Mutant Strain Induces Host Protection against Multiple Invasive Mycoses in a Murine Vaccine ModelSemantic proximity Read ↗

Development of vaccines for Candida albicans: fighting a skilled transformer.Semantic proximity Read ↗

Immunological correlates of protection mediated by a whole organism <i>Cryptococcus neoformans</i> vaccine deficient in chitosanSemantic proximity Read ↗

Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.Semantic proximity Read ↗

Differential virulence of Candida glabrata glycosylation mutants.Semantic proximity Read ↗

Non-canonical Activities of Hog1 Control Sensitivity of Candida albicans to Killer Toxins From Debaryomyces hansenii.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.